RxDoctor Payments Data

Eric Tan, MD

Foot and Ankle Surgery · Los Angeles, CANPI 1811130743

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $335,993 of the $446,726 with a category attached, or 75.2%. Stryker accounts for 80.8% of it on its own, with 19 other manufacturers making up the rest. 2025 is the largest year on record at $141,552, 5.0 times the $28,204 reported in 2019. Among foot and ankle surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$446,726in general payments, 2019–2025

Across 480 payments — averaging $930.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$361K
  • Arthrex$81K
  • Acumed LLC$2K
  • Zimmer Biomet$417
  • Treace Medical Concepts, Inc.$367
  • Micromed Inc$318
  • plus $2K from 14 others

What the payments were for

  • Consulting fees$335,99375%
  • Speaking & faculty fees$53,02012%
  • Travel & lodging$42,4309%
  • Food & beverage$15,0453%
  • Entertainment$2380%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$446,726 in reported general payments places this provider in the 95th percentile of 1,126 foot and ankle surgery providers in California.

See all foot and ankle surgery providers in California

Medicare billing

Part B allowed, 2024
$197,545
Medicare patients
515
Services billed
1,674

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Vancomycin Hcl15$2,791
Tramadol Hcl31$171
Diclofenac Sodium12$161
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim27$116
Gabapentin16$102

Paid to pharmacies, not to this prescriber.

Other foot and ankle surgery in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →